Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multicenter, Blinded, Randomized, Controlled, Parallel, Comparative Study for the Evaluation of Safety and Efficacy of rhFSH Injection Compared With Gonal-F® Pen Undergoing Controlled Ovarian Hyper Stimulation IVF-ET

NCT03506243 is registered in ClinicalTrials.gov with Hangzhou YuYuan Bioscience Technology Co., Ltd. as lead sponsor.

NCT NCT03506243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03506243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multicenter, Blinded, Randomized, Controlled, Parallel, Comparative Study for the Evaluation of Safety and Efficacy of rhFSH Injection Compared With Gonal-F® Pen Undergoing Controlled Ovarian Hyper Stimulation IVF-ET
Lead sponsor
Hangzhou YuYuan Bioscience Technology Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2015
Completion date
May 31, 2017
Enrollment
451 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, female